Once-a-Month shot could ease anemia for kidney patients

NCT ID NCT00661388

Completed Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a monthly injection of Mircera in 75 adults with chronic kidney disease who were not yet on dialysis and had anemia. The goal was to see if the drug could safely raise and maintain hemoglobin levels. Results showed improvement in hemoglobin during the evaluation period.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: methoxy polyethylene glycol-epoetin beta (Mircera)
What this could lead to: If successful, this could provide a convenient once-monthly treatment option for managing anemia in pre-dialysis patients.
What could go wrong: This is a completed Phase 3 trial, but results may not apply to all patients. Risks include high blood pressure and bleeding, and the treatment does not cure kidney disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEMIA

Contacts and locations

Locations

Study site

Ankara, 06100, Turkey (Türkiye)
Study site

Denizli, 20100, Turkey (Türkiye)
Study site

Edirne, 22030, Turkey (Türkiye)
Study site

Istanbul, 34000, Turkey (Türkiye)
Study site

Istanbul, 34377, Turkey (Türkiye)
Study site

Istanbul, 34381, Turkey (Türkiye)
Study site

Istanbul, 34390, Turkey (Türkiye)
Study site

Kahramanmaraş, 46100, Turkey (Türkiye)
Study site

Konya, 42770, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.